Engineering Biology for Science & Industry: Accelerating Progress
Follow up meeting to discuss next steps and initiate serious planning to develop the thoughts and ideas discussed in April.
Topics of discussion will include the identification of some large pools of federal funding ($50 to $170 million over five years) that present potential opportunities for support, additional programs that can support policy development, public engagement as well as ethical and security issues. Lastly, we will begin some road mapping activities during the meeting.
Sponsored By
Spencer Adler
Our Speakers
David Rejeski
Director, Science & Technology Innovation Progam
Wilson Center
Todd Kuiken
Woodrow Wilson Center
Megan Palmer
Perry Fellow in International Security
CISAC, Stanford University
Jef Boeke
Director
NYU Langone Medical Center
Virginia Cornish
Helena Rubinstein Chair
Columbia University
Jeff Hammerbacher
Founder and Chief Scientist
Cloudera
Melissa Rhoads
Ellen Jorgensen
Director
Genspace NYC
Tracy Lessor, PhD, MBA, ELS
Senior Leader, Science Communications
Feinstein Kean Healthcare
Natalie Kuldell
President, Founder
BioBuilder Educational Foundation
Michael Loukides
Vice President of Content Strategy
O'Reilly Media, Inc.
Philip Dormitzer
Head of Research and Vice President
Novartis Influenza Vaccines
Bill Peck
CTO
Twist Bioscience
Gilonne d'Origny
CFO
New Harvest
Breton Hornblower
Product Marketing Manager
New England Biolabs
Farren Isaacs
Assistant Professor
Yale
Community
New England Biolabs
SQream Technologies
Bioeconomy Capital
CISAC, Stanford University
Twist Bioscience
Columbia University
Wilson Center
Karen Ingram & Associates, Inc.
Gen9 Inc.
NYU, Synthetic Genomics
Yale
New Harvest
New England Biolabs
Genspace NYC
Twist Bioscience
Nancy J Kelley & Associates
New York Genome Center, 101 Avenue of the Americas, New York, NY, United States
DOWNLOAD OUR EVENT APP
Download Bizzabo
